Creatine Kinase (CK)
Females, Age 60-69
The median creatine kinase (CK) for US females aged 60-69 is 86 U/L, with 90% of the population falling between 41.4 U/L and 234.5 U/L.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 738 participants · Unit: U/L
Percentile Distribution
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (U/L) | 41.4 | 47 | 64 | 86 | 121.7 | 177 | 234.5 |
| 95% CI | 38 | 43 | 57.9 | 78 | 112.8 | 161.3 | 193 |
| Percentile | Value (U/L) | 95% CI |
|---|---|---|
| P5 | 41.4 | 38 |
| P10 | 47 | 43 |
| P25 | 64 | 57.9 |
| P50 | 86 | 78 |
| P75 | 121.7 | 112.8 |
| P90 | 177 | 161.3 |
| P95 | 234.5 | 193 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
64 86 121.7
P25 P50 P75
P5 41.4 P95 234.5
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from the full MEC sample)
- Survey years
- 2017-2020
- Measurement
- Measured by coupled enzymatic rate assay on Roche Cobas 6000 (c501 module). How it was measured
- Sample size
- 738 participants
- Reference population
- US civilian non-institutionalized females aged 60-69 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing creatine kinase value (LBXSCK)
- Missing or zero combined pre-pandemic MEC sample weight (WTMECPRP)
- Age outside 60-69 range
- Notes
- Percentiles computed using the combined pre-pandemic MEC weight (WTMECPRP). Creatine kinase measured as LBXSCK; the NHANES codebook labels the unit IU/L, which is the same unit as U/L.